Press Release
|
Management Commentary
Our third quarter results reflect the completion of initial volume production orders under our outsourced manufacturing model. Since July, we have delivered 10,000 parts per month to fill a customer pipeline for a dental application. We expect continued deliveries, at similar volumes, to continue into the middle of 2021. This has allowed us to further validate Yihao as a trusted supplier and technology partner. These successful initial volume production runs are expected to further drive customer confidence in our technology, identify areas of improvement in our operating model, and increase market confidence in the viability of our breakthrough technology in critical fielded products. Concurrently, we continue to execute aggressive sales and marketing programs to add new projects to our pipeline and are developing opportunities for additional licensed manufacturers with domestic operations.
Q3 2020 Financial Summary
During the third quarter of 2020, the Company generated
Cost of goods sold was
Selling, marketing, general and administrative expense was
Research and development decreased to
Cash and cash equivalents, restricted cash, and investments in debt securities totaled
For a more detailed and complete analysis of the Company’s financial results, please refer to the Company’s
About
Forward-Looking Statement
This press release contains "forward-looking statements," including but not limited to statements regarding the advantages of
CONSOLIDATED BALANCE SHEETS (in thousands, except par value and share data) |
||||||||
|
|
|
||||||
2020 |
|
2019 |
||||||
(Unaudited) |
|
(Audited) |
||||||
ASSETS | ||||||||
Current assets: | ||||||||
Cash and cash equivalents |
$ |
5,438 |
|
$ |
19,543 |
|
||
Restricted cash |
|
5 |
|
|
5 |
|
||
Investments in debt securities- short term |
|
11,566 |
|
|
4,415 |
|
||
Trade accounts receivable, net of allowance for doubtful accounts |
|
182 |
|
|
303 |
|
||
Inventory |
|
47 |
|
|
12 |
|
||
Prepaid expenses and other current assets |
|
600 |
|
|
322 |
|
||
Total current assets |
$ |
17,838 |
|
$ |
24,600 |
|
||
Investments in debt securities- long term |
|
12,279 |
|
|
7,074 |
|
||
Property and equipment, net |
|
8,694 |
|
|
8,819 |
|
||
Patents and trademarks, net |
|
177 |
|
|
239 |
|
||
Equipment held for sale |
|
- |
|
|
585 |
|
||
Other assets |
|
235 |
|
|
14 |
|
||
Total assets |
$ |
39,223 |
|
$ |
41,331 |
|
||
LIABILITIES AND SHAREHOLDERS' EQUITY | ||||||||
Current liabilities: | ||||||||
Accounts payable |
|
316 |
|
|
132 |
|
||
Accrued liabilities |
|
310 |
|
|
775 |
|
||
Total current liabilities |
$ |
626 |
|
$ |
907 |
|
||
Long-term liabilities | ||||||||
Other long-term liabilities |
|
899 |
|
|
856 |
|
||
Total liabilities |
$ |
1,525 |
|
$ |
1,763 |
|
||
Shareholders' equity: | ||||||||
Preferred Stock, |
|
- |
|
|
- |
|
||
Common stock, |
|
914 |
|
|
914 |
|
||
Warrants |
|
18,179 |
|
|
18,179 |
|
||
Additional paid-in capital |
|
287,088 |
|
|
286,832 |
|
||
Accumulated deficit |
|
(268,449 |
) |
|
(266,284 |
) |
||
Accumulated other comprehensive income |
|
42 |
|
|
2 |
|
||
Non-controlling interest in subsidiary |
|
(76 |
) |
|
(75 |
) |
||
Total shareholders' equity |
$ |
37,698 |
|
$ |
39,568 |
|
||
Total liabilities and shareholders' equity |
$ |
39,223 |
|
$ |
41,331 |
|
||
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (in thousands, except share and per share data) (unaudited) |
||||||||||||||||
For the Three Months
|
|
For the Nine Months
|
||||||||||||||
2020 |
|
2019 |
|
2020 |
|
2019 |
||||||||||
Revenue | ||||||||||||||||
Products |
$ |
288 |
|
$ |
373 |
|
$ |
367 |
|
$ |
728 |
|
||||
Licensing and royalties |
|
39 |
|
|
48 |
|
|
64 |
|
|
48 |
|
||||
Total revenue |
|
327 |
|
|
421 |
|
|
431 |
|
|
776 |
|
||||
Cost of sales |
|
171 |
|
|
284 |
|
|
242 |
|
|
566 |
|
||||
Gross profit (loss) |
|
156 |
|
|
137 |
|
|
189 |
|
|
210 |
|
||||
Operating expenses | ||||||||||||||||
Selling, marketing, general and administrative |
|
1,096 |
|
|
1,380 |
|
|
2,953 |
|
|
4,088 |
|
||||
Research and development |
|
30 |
|
|
284 |
|
|
86 |
|
|
1,179 |
|
||||
Impairment of long-lived assets |
|
- |
|
|
- |
|
|
- |
|
|
1,676 |
|
||||
(Gain) on disposal of long-lived assets |
|
- |
|
|
(7 |
) |
|
(35 |
) |
|
(2 |
) |
||||
Total operating expenses |
|
1,126 |
|
|
1,657 |
|
|
3,004 |
|
|
6,941 |
|
||||
Operating loss |
|
(970 |
) |
|
(1,520 |
) |
|
(2,815 |
) |
|
(6,731 |
) |
||||
Lease income |
|
132 |
|
|
- |
|
|
352 |
|
|
- |
|
||||
Interest and investment income |
|
61 |
|
|
125 |
|
|
297 |
|
|
344 |
|
||||
Loss before income taxes |
|
(777 |
) |
|
(1,395 |
) |
|
(2,166 |
) |
|
(6,387 |
) |
||||
Income taxes |
|
- |
|
|
- |
|
|
- |
|
|
- |
|
||||
Net loss |
|
(777 |
) |
|
(1,395 |
) |
|
(2,166 |
) |
|
(6,387 |
) |
||||
Net loss attributable to non-controlling interest |
|
1 |
|
|
- |
|
|
1 |
|
|
1 |
|
||||
Net loss attributable to |
$ | (776 | ) | $ | (1,395 | ) | $ | (2,165 | ) | $ | (6,386 | ) | ||||
Per common share basic and diluted: | ||||||||||||||||
Net loss per common share attributable to |
$ | (0.00 | ) | $ | (0.00 | ) | $ | (0.00 | ) | $ | (0.01 | ) | ||||
Number of weighted average shares - basic and diluted |
|
914,449,957 |
|
|
914,359,124 |
|
|
914,449,957 |
|
|
914,332,758 |
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20201110006206/en/
Bryce Van
Media Relations
949-635-2107
bryce.van@liquidmetal.com
Source: